Deltagen Names New VP, Pharmaceutical Development | GenomeWeb

NEW YORK, March 26 – Dan Shochat, a former chief scientific officer and senior vice president at Coulter Pharmaceutical, has joined Deltagen as vice president of pharmaceutical development, the company said Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.